期刊文献+

盐酸吉西他滨联合立体定向放疗治疗局部晚期胰腺癌的效果评价 被引量:10

Therapeutic effect of gemcitabine hydrochloride combined with stereotactic radiotherapy for locally advanced pancre-atic cancer
下载PDF
导出
摘要 目的评价盐酸吉西他滨联合立体定向放疗治疗局部晚期胰腺癌的临床疗效。方法收集2008年6月-2013年6月福州总医院收治的初治无法手术切除的局部晚期胰腺癌患者122例,按治疗方法分为盐酸吉西他滨联合立体定向放疗治疗(A组,n=56)和吉西他滨单药治疗(B组,n=66)。记录治疗后患者病情变化情况、毒副反应及死亡时间。计数资料组间比较采用χ2检验,采用Kaplan-Meier法绘制生存曲线。结果 A组治疗后有效率67.8%(38/56),B组治疗后有效率22.7%(15/66),2组比较差异有统计学意义(χ2=25.11,P<0.01);A组止痛有效率95.8%,B组止痛有效率77.2%,2组比较差异有统计学意义(χ2=7.39,P<0.01);A组1年生存率58.9%(33/56),2年生存率28.6%(16/96),中位生存时间12.8个月,B组1年生存率31.8%(21/66),2年生存率10.6%(7/66),中位生存时间7.9个月,两组比较差异均有统计学意义(χ2分别为9.03、6.39、15.51,P值均<0.01)。结论盐酸吉西他滨联合立体定向放疗具有较好的近远期疗效,毒副反应能够耐受。 Objective To investigate the clinical therapeutic effect of gemcitabine hydrochloride combined with stereotactic radiotherapy for locally advanced pancreatic cancer. Methods A total of 122 previously untreated patients with locally advanced pancreatic cancer who were not able to undergo surgical resection and were admitted to Fuzhou General Hospital from June 2008 to June 2013 were selected,and according to the therapies,they were divided into the group with a combination of gemcitabine hydrochloride and stereotactic radiotherapy( group A,n = 56) and the group with gemcitabine therapy alone( group B,n = 66). The changes in condition,toxic and side effects,and death time were recorded. The chi- square test was applied for comparison between groups,and the Kaplan- Meier method was applied for plotting survival curves. Results There was a significant difference in response rate between group A and group B [67. 8%( 38 /56) vs22. 7%( 15 /66),χ2= 25. 11,P 〈 0. 01]; the effective pain- relieving rate showed a significant difference between group A and group B( 95. 8% vs 77. 2%,χ2= 7. 39,P 〈 0. 01); there were significant differences in 1- year survival rate,2- year survival rate,and median survival time between the two groups [58. 9%( 33 /56) vs 31. 8%( 21 /66),χ2= 9. 03,P 〈 0. 01; 28. 6%( 16 /56) vs 10. 6%( 7 /66),χ2= 6. 39,P 〈 0. 01; 12. 8 months vs 7. 9 months; χ2= 15. 51,P 〈 0. 01]. Conclusion Gemcitabine hydrochloride combined with stereotactic radiotherapy has good short- and long- term efficacy,and toxic and side effects are tolerable.
出处 《临床肝胆病杂志》 CAS 2016年第3期537-540,共4页 Journal of Clinical Hepatology
关键词 胰腺肿瘤 放射外科手术 药物疗法 治疗结果 pancreatic neoplasms radiosurgery drug therapy treatment outcome
  • 相关文献

参考文献5

二级参考文献67

  • 1赵玉沛,张太平.胰腺癌早期诊断若干问题探讨[J].中华肝胆外科杂志,1998,4(5):269-272. 被引量:4
  • 2沈魁.胰腺癌诊断的经验和体会[J].中国实用外科杂志,1995,15(4):197-198. 被引量:8
  • 3潘德键,王标,周锡建,王东林,李相勇,范晓强,周仁贵,唐新宇.盐酸吉西他滨单药联合伽玛刀治疗晚期胰腺癌的疗效观察[J].中华全科医师杂志,2007,6(8):500-502. 被引量:1
  • 4Calculli L, Casadei R, Diacono D, et al. Role of spiral computerized tomography in the staging of pancreatic carcinoma. Radiol Med, 1998, 95: 344-348.
  • 5陈东福等著,殷蔚伯,谷铣之.肿瘤放射治疗学[M]中国协和医科大学出版社,2002.
  • 6Allen AM,Zalupski MM,Robertson JM,et al.Adjuvant therapyin pancreatic cancer:PhaseⅠtrial of radiation dose escalationwith concurrent full-dose gemcitabine. International Journal of Radiation Oncology Biology Physics . 2004
  • 7Ito Y,Okusaka T,Kagmi Y,et al.Evaluation of acute intestinaltoxicity in relation to the volume of irradiated small bowel in pa-tients treated with concurrent weekly gemcitabine and radiothera-py for locally advanced pancreatic cancer. Anticancer Research . 2006
  • 8Reni M,Cordio S,Milandri C,et al.Gemcitabine versus cispla-tin,epirubicin,fluorouracil,and gemcitabine in advanced pan-creatic carcinoma:a randomized controlled multicentre phase?trial. The Lancet Oncology . 2005
  • 9Cunningham D,Chau I,Stocken DD,et al.PhaseⅢrandom-ized comparison of gemcitabine(GEM)versus gemcitabine pluscapecitabine(GEM-CAP)in patients with advanced pancreaticcancer. Journal of Clinical Oncology . 2009
  • 10Herrmann R,Bodoky G,Ruhstaller T,et al.Gemcitabine puscapecitabine compared with gemcitabine alone in advanced pan-creatic cancer.a randomized,multicenter,phaseⅢtrial of theSwiss Group for Clinical Cancer Research and the Central Euro-pean Cooperative Oncology Group. Journal of Clinical Oncology . 2007

共引文献62

同被引文献93

引证文献10

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部